FAVALLI, ANDREA
 Distribuzione geografica
Continente #
EU - Europa 338
NA - Nord America 195
AS - Asia 134
OC - Oceania 3
SA - Sud America 2
Totale 672
Nazione #
US - Stati Uniti d'America 193
IT - Italia 120
DE - Germania 78
SG - Singapore 68
IE - Irlanda 65
CN - Cina 29
RU - Federazione Russa 27
HK - Hong Kong 20
SE - Svezia 16
ID - Indonesia 15
FI - Finlandia 9
NL - Olanda 8
GB - Regno Unito 4
AU - Australia 3
BE - Belgio 3
BR - Brasile 2
CA - Canada 2
IN - India 2
UA - Ucraina 2
AT - Austria 1
CH - Svizzera 1
CZ - Repubblica Ceca 1
DK - Danimarca 1
FR - Francia 1
RO - Romania 1
Totale 672
Città #
Frankfurt am Main 70
Dublin 65
Singapore 65
Milan 47
Chandler 28
Ann Arbor 25
New York 22
Hong Kong 20
Santa Clara 20
Shanghai 18
Jakarta 15
Ashburn 10
Florence 8
Helsinki 7
Piacenza 4
Romola 4
Amsterdam 3
Brescia 3
Brussels 3
Chicago 3
Darlington 3
Los Angeles 3
The Bronx 3
Atlanta 2
Bari 2
Bergamo 2
Boardman 2
Carate Brianza 2
Fairfield 2
Huizen 2
Lappeenranta 2
London 2
Monza 2
Munich 2
Novate Milanese 2
Princeton 2
Pune 2
Ripalta Cremasca 2
Slough 2
Sulmona 2
São Paulo 2
Airuno 1
Biandronno 1
Bonndorf 1
Brno 1
Casalecchio di Reno 1
Cinisello Balsamo 1
Cuasso al Monte 1
Dallas 1
Dalmine 1
Deiva Marina 1
Fremont 1
Groningen 1
Lavis 1
Lawrence 1
Melzo 1
Muggiò 1
Notre Dame 1
Nuremberg 1
Ottawa 1
Pavia 1
Pioltello 1
Rho 1
Rotterdam 1
Samolaco 1
Shijiazhuang 1
Toronto 1
Trescore Balneario 1
Vienna 1
Washington 1
Wilmington 1
Xi'an 1
Xingtai 1
Zurich 1
Totale 518
Nome #
Untargeted Mass Spectrometry Approach to Study SARS-CoV-2 Proteins in Human Plasma and Saliva Proteome 129
Integrated longitudinal immunophenotypic, transcriptional and repertoire analyses delineate immune responses in COVID-19 patients 126
Plasma proteome investigation of COVID-19 patients with different outcomes through an untargeted label-free LC-MS/MS approach. 84
Untargeted mass spectrometry approach to study SARS-CoV-2 proteins and characterize human plasma and saliva proteome in COVID-19 patients. 79
Plasma Proteomic Variables Related to COVID-19 Severity: An Untargeted nLC-MS/MS Investigation 73
Immunosuppressant Treatment in Rheumatic Musculoskeletal Diseases Does Not Inhibit Elicitation of Humoral Response to SARS-CoV-2 Infection and Preserves Effector Immune Cell Populations 54
Immune response to SARS-CoV-2 natural infection and vaccination in healthy subjects and in immunocompromised patients 46
Corrigendum: The Impact of Anti-rheumatic Drugs on the Seroprevalence of Anti-SARS-CoV-2 Antibodies in a Cohort of Patients With Inflammatory Arthritis: The MAINSTREAM Study(Front. Med., (2022), 9, (850858), 10.3389/fmed.2022.850858) 45
Plasma proteomic signatures related to COVID-19 disease severity by an untargeted nLC-ESI-MS/MS approach 34
Characterization of SARS-CoV-2 proteins and human proteome in COVID-19 patients’ saliva and plasma: an untargeted mass spectrometry approach 34
Totale 704
Categoria #
all - tutte 3.869
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 3.869


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/202235 0 0 0 0 0 0 0 6 1 0 12 16
2022/2023213 15 37 26 50 12 25 5 11 14 6 9 3
2023/2024226 2 9 13 20 18 62 40 14 11 8 4 25
2024/2025230 20 58 39 44 35 34 0 0 0 0 0 0
Totale 704